Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2012 to 2061 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphofurin acidic cluster sorting protein 1 isoform 1; cytosolic sorting protein pacs-1. [source:refseq;acc:nm\_018026]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2805\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate kinase 1 (ec 2.7.2.3) (primer recognition protein 2) (prp 2). [source:swissprot;acc:p00558]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
946\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6598.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7241.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09744\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate kinase, testis specific (ec 2.7.2.3). [source:swissprot;acc:p07205]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
942\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6597.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7240.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1113\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1114\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoinositide-3-kinase, class 2, alpha polypeptide; c2-containing phosphatidylinositol kinase. [source:refseq;acc:nm\_002645]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6326.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6762.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06892\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoinositide-3-kinase, class 3; vps34; phosphatidylinositol 3-kinase, class 3. [source:refseq;acc:nm\_002647]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3173\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipase d1 (ec 3.1.4.4) (pld 1) (choline phosphatase 1) (phosphatidylcholine-hydrolyzing phospholipase d1) (hpld1). [source:swissprot;acc:q13393]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1622\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6153.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6589.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07081\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipase d2 (ec 3.1.4.4) (pld 2) (choline phosphatase 2) (phosphatidylcholine-hydrolyzing phospholipase d2) (pld1c) (hpld2). [source:swissprot;acc:o14939]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1626\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6157.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6591.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07055\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid scramblase 2 (pl scramblase 2) (ca(2+)-dependent phospholipid scramblase 2). [source:swissprot;acc:q9nry7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6260.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6685.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06783\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid scramblase 3 (pl scramblase 3) (ca(2+)-dependent phospholipid scramblase 3). [source:swissprot;acc:q9nry6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6259.8\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6684.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06782\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid scramblase 4 (pl scramblase 4) (ca(2+)-dependent phospholipid scramblase 4). [source:swissprot;acc:q9nrq2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1730\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6684.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid transfer protein precursor (lipid transfer protein ii). [source:swissprot;acc:p55058]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2339\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5123.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5350.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1026\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5509.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6029.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09427\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1025\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5511.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6031.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoribosyl pyrophosphate synthetase-associated protein 1 (prpp synthetase-associated protein 1) (39 kda phosphoribosypyrophosphate synthetase-associated protein) (pap39). [source:swissprot;acc:q14558]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2869\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoribosyl pyrophosphate synthetase-associated protein 2 (prpp synthetase-associated protein 2) (41 kda phosphoribosypyrophosphate synthetase-associated protein) (pap41). [source:swissprot;acc:o60256]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2943\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoribosylformylglycinamidine synthase (ec 6.3.5.3) (fgam synthase) (fgams) (formylglycinamide ribotide amidotransferase) (fgarat) (formylglycinamide ribotide synthetase). [source:swissprot;acc:o15067]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2461\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5114.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5272.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03105\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pinch protein (particularly interesting new cys-his protein) (lim and senescent cell antigen-like domains 1). [source:swissprot;acc:p48059]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1868\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1227\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5973.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6483.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
placenta growth factor precursor (plgf). [source:swissprot;acc:p49763]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3036\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
placental protein 11 precursor (ec 3.4.21.-) (pp11). [source:swissprot;acc:p21128]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3076\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2409\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
241\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2407\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
platelet-activating factor acetylhydrolase ib alpha subunit (ec 3.1.1.47) (paf acetylhydrolase 45 kda subunit) (paf-ah 45 kda subunit) (paf-ah alpha) (pafah alpha) (lissencephaly-1 protein) (lis- 1). [source:swissprot;acc:p43034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3221\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pleckstrin homology domain containing, family c (with ferm domain) member 1; mitogen inducible 2; kindlin 2. [source:refseq;acc:nm\_006832]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1878\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
332\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5051.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5975.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.183\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6231.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6933.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
306\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13680.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11409.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pogo transposable element with znf domain isoform 1. [source:refseq;acc:nm\_015100]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2932\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly (adp-ribose) glycohydrolase. [source:refseq;acc:nm\_003631]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
840\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5786.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6395.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10526\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
285\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23326.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19296.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
287\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23303.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19279.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1091\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1094\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
643\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4810.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5414.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12542\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polybromo 1. [source:refseq;acc:nm\_018165]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2052\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5634.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5952.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyglutamine binding protein 1; nuclear protein containing ww domain 38 kd. [source:refseq;acc:nm\_005710]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2579\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4979.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5071.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyhomeotic like 3; early development regulator 3; polyhomeotic 3. [source:refseq;acc:nm\_024947]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2809\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (dna directed) iota; rad30 (s. cerevisiae) homolog b; polymerase (dna-directed), iota. [source:refseq;acc:nm\_007195]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
283\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5221.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6314.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
765\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4726.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5258.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (32kd). [source:refseq;acc:nm\_006467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2583\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3926.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3857.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (62kd). [source:refseq;acc:nm\_006468]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3985.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3928.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymerase delta-interacting protein 1; tnfaip1-like. [source:refseq;acc:nm\_178863]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1156\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5840.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08819\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polymyositis/scleroderma autoantigen 2 (autoantigen pm/scl 2) (polymyositis/scleroderma autoantigen 100 kda) (pm/scl-100) (p100 polymyositis-scleroderma overlap syndrome associated autoantigen). [source:swissprot;acc:q01780]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6141.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6291.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polypeptide n-acetylgalactosaminyltransferase 2; udp-galnac transferase 2. [source:refseq;acc:nm\_004481]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2097\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6024.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6356.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyposis locus protein 1 (tb2 protein). [source:swissprot;acc:q00765]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2611\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01498\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/